DXB 9.76% 45.0¢ dimerix limited

Ann: Ethics Committee Approval for Pharmacokinetic Trial, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,203 Posts.
    lightbulb Created with Sketch. 786
    Typical misrepresentation or musunderstanding of the facts: Dr Williams states that it may delay the need for dialysis for 3-5 years. Reporter claims this could mean the end of the need for dialysis.

    The clip also states that the trial will be for healthy patients - wasn't that Phase 1?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.